CHF Solutions, Inc. (CHFS) News
Filter CHFS News Items
CHFS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CHFS News Highlights
- For CHFS, its 30 day story count is now at 2.
- Over the past 12 days, the trend for CHFS's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- MD, IR and SAFE are the most mentioned tickers in articles about CHFS.
Latest CHFS News From Around the Web
Below are the latest news stories about CHF Solutions Inc that investors may wish to consider to help them evaluate CHFS as an investment opportunity.
CHF Solutions Announces First Patient Enrolled in the ULTRA-Peds RegistryRegistry will Support Real-World Efficacy of Fluid Management in ChildrenEDEN PRAIRIE, Minn., April 20, 2021 (GLOBE NEWSWIRE) -- More pediatric clinical evidence is essential in understanding the real-world benefits of medical devices in children. CHF Solutions is committed to expanding pediatric-specific data, and today announced Joe DiMaggio Children’s Hospital in Hollywood, Florida has enrolled the first patient in the Ultrafiltration Therapy Registry Using Aquadex (ULTRA-Peds Registry). ULTRA-Peds will collect real-world evidence on the safety, performance and utilization of Aquadex SmartFlow® in fluid overloaded children who weigh 20 kg or more. CHF Solutions is the sponsor of the registry alongside collaborator Acute Kidney Injury Critical Care Research Foundation. Key clinical da... |
The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill Patients Have Access to Life-Saving Ultrafiltration TherapyNew Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting (NKF)EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) -- Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) using the Aquadex SmartFlow® system by CHF Solutions may be lifesaving for patients with profound and catastrophic multi-organ failure due to fluid overload, in part due to the device’s flexibility and portability. Aquadex™ gently removes excess fluid from the blood to alleviate burden on key organs such as the kidneys and heart. The case study, “Aquapheresis for Life-threatening Cardio-Respiratory Failure,” is part of an abstrac... |
CHF Solutions, Inc. Announces Closing of $20.9 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment OptionEDEN PRAIRIE, Minn., March 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the closing of its previously announced underwritten public offering of 3,795,816 shares of its common stock at a price to the public of $5.50 per share, for gross proceeds of approximately $20.9 million, including the full exercise of the underwriters’ over-allotment option to purchase additional shares of the Company’s common stock, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. Ladenburg Thalmann & Co. Inc. acted as sole book-running manager in connection with the offering. Lake Street Capital Markets, LLC acted as lead manager for the offering. Colliers Securities LLC and Maxim Group LLC acted as financial ... |
CHF Solutions, Inc. Announces Pricing of $18.1 Million Underwritten Public Offering of Common StockEDEN PRAIRIE, Minn., March 17, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the pricing of an underwritten public offering of 3,300,710 shares of its common stock at a price to the public of $5.50 per share, for gross proceeds of approximately $18.1 million prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The Company has granted the underwriters an option, exercisable in whole or in part for 45 days, to purchase up to an additional 495,106 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager in connection with the offering. Lake Street Capital Markets, LLC is acting a... |
CHF Solutions, Inc. Announces Proposed Underwritten Public Offering of Common StockEDEN PRAIRIE, Minn., March 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten public offering. All of the shares of common stock to be sold in the offering will be offered by the Company. The Company intends to grant the underwriters a 45-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. The Company intends to use the net proceeds for the offering for general corporate purposes, including the continued investment in commercialization efforts. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms ... |
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)EDEN PRAIRIE, Minn., March 05, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS), today announced that, effective February 17, 2021, the independent directors approved one equity award under CHF Solution’s New-Hire Equity Incentive Plan, as material inducement to an individual entering into employment with the company. The equity award was approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan. In connection with entering into employment with CHF Solutions, the individual, who was not previously an employee or director of CHF Solutions, received an option to purchase an aggregate of 300 shares of the Company’s common stock. The option award has an exercise... |
CHF Solutions (NASDAQ:CHFS) Releases Quarterly Earnings Results, Beats Expectations By $0.34 EPSCHF Solutions (NASDAQ:CHFS) posted its quarterly earnings data on Monday. The company reported ($1.57) EPS for the quarter, beating the consensus estimate of ($1.91) by $0.34, Fidelity Earnings reports. CHF Solutions had a negative return on equity of 173.61% and a negative net margin of 254.26%. NASDAQ CHFS opened at $8.03 on Thursday. The company’s […] |
ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery PatientsEDEN PRAIRIE, Minn., March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will participate in the first ERAS Cardiac Society Virtual Conference, broadcasting Live from Methodist Hospital DeBakey Center in Houston, Texas on March 5-6, 2021. Daniel Beckles, MD, PhD, FACS, Surgical Director Heart of Transplantation and MCS at Baylor Scott & White Health Central Texas, will present an on-demand lecture on the management of fluid overload with Aquadex™ ultrafiltration therapy. He will discuss the morbidity and mortality issues surrounding fluid overload in patients undergoing cardiac surgery, the cardio-renal connection, and how to best manage these patients. Dr. Beckles will share... |
CHF Solutions: Q4 Earnings InsightsShares of CHF Solutions (NASDAQ:CHFS) moved higher by 4.6% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings … |
CHF Solutions Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysisCHF Solutions announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by… |